Gilead Sciences (BUE:GILD) Machinery, Furniture, Equipment : ARS385,909 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Gilead Sciences Machinery, Furniture, Equipment?

Gilead Sciences's Machinery, Furniture, Equipment for the quarter that ended in Dec. 2023 was ARS385,909 Mil.

Gilead Sciences's quarterly Machinery, Furniture, Equipment stayed the same from Jun. 2023 (ARS0 Mil) to Sep. 2023 (ARS0 Mil) but then increased from Sep. 2023 (ARS0 Mil) to Dec. 2023 (ARS385,909 Mil).

Gilead Sciences's annual Machinery, Furniture, Equipment increased from Dec. 2021 (ARS81,499 Mil) to Dec. 2022 (ARS147,532 Mil) and increased from Dec. 2022 (ARS147,532 Mil) to Dec. 2023 (ARS385,909 Mil).

Gilead Sciences Machinery, Furniture, Equipment Historical Data

The historical data trend for Gilead Sciences's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gilead Sciences Machinery, Furniture, Equipment Chart

Gilead Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Machinery, Furniture, Equipment

Get a 7-Day Free Trial

37,896.46

64,534.34

81,498.93

147,532.00

385,909.00

Gilead Sciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Machinery, Furniture, Equipment	Get a 7-Day Free Trial															147,532.00	-	-	-	385,909.00

Gilead Sciences Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.

Gilead Sciences (BUE:GILD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gilead Sciences Inc (BUE:GILD) » Definitions » Machinery, Furniture, Equipment

Comparable Companies

Traded in Other Exchanges

GILD:USA GILD:Mexico GILD:Italy GISd:UK 0QYQ:UK GIS:Germany GIS:Germany GIS:Germany GIS:Germany GILD34:Brazil GILD:Austria

Address

333 Lakeside Drive, Foster, CA, USA, 94404

Website

https://www.gilead.com

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.